What a DKP is
DKPs are the smallest possible cyclic peptides: two amino acids joined head-to-tail into a six-membered ring with two carbonyls flanking two nitrogens. Stereochemistry at each residue governs structure-activity relationships, and the cyclic backbone is chemically stable when stored appropriately.
Key takeaways
- Stereochemistry is non-negotiable for DKP SAR: D-configured residues favor aromatic or methionine-containing rings, while L-configured residues favor branched-chain amino acids.
- Glycine substitution at the proline position increased autophagic flux in some scaffolds, giving chemists a second tunable handle beyond configuration.
- The GFP-LC3-RFP tandem probe reports true flux because GFP is acid-quenched in the lysosome while RFP survives, a yellow-to-red shift beats LC3-II Westerns alone.
- Pair any autophagy induction claim with phospho-S6K or phospho-4EBP1 controls; without them you cannot distinguish mTORC1-dependent from mTORC1-independent mechanisms.
- Store DKP stocks dry at –20 °C or colder; trace moisture and acid catalyze epimerization and erode lot-to-lot activity even on a stable cyclic backbone.
In this article
Autophagy, the cell's recycling system, has become one of the most chased targets in aging and metabolic disease research. The problem is that the standard pharmacological lever, mechanistic target of rapamycin complex 1 (mTORC1) inhibition, drags along immunosuppression and insulin resistance as unwanted passengers.
A new preprint from bioRxiv takes a different route: it screens a chemically clean library of 2,5-diketopiperazines (DKPs) and finds four that turn the autophagy machinery without touching the canonical mTORC1 readout.
What a 2,5-diketopiperazine actually is
DKPs are the smallest possible cyclic peptides, two amino acids joined head-to-tail into a six-membered ring with two carbonyls flanking two nitrogens. That ring is rigid, protease-resistant, and densely hydrogen-bonding, which is why these scaffolds keep showing up in natural products, drug discovery, and food chemistry.
The catch: under conventional peptide coupling conditions, the alpha-carbon of each residue racemizes freely, so a "DKP" from a standard synthesis is really a mixture of up to four stereoisomers per pair of residues. That ambiguity has blocked any clean structure-activity relationship for decades.
Chemoenzymatic synthesis preserves stereochemistry
The Cold Spring Harbor / Caltech / Imperial team solved that with a one-pot chemoenzymatic route built on the adenylation domain of tyrocidine synthetase A (TycA). The enzyme activates one residue as an aminoacyl-AMP while leaving the alpha-carbon configuration intact, then a second residue closes the ring. The output is a library of DKPs with defined stereochemistry at every position, the prerequisite for the SAR work that follows.
The screen that picked the winners
Rather than chasing a single biochemical target, the group ran a phenotypic screen in Caco-2 cells stably expressing a tandem GFP-LC3-RFP autophagic flux probe. The logic is elegant: GFP is quenched in the acidic lysosome while RFP is not, so a shift from yellow (GFP+RFP, autophagosome) to red (RFP-only, autolysosome) reports true flux, not just LC3 lipidation.
Four hits came out of this screen: c(DW-DP), c(DW-LP), c(DF-DP), and c(DM-LP), where single letters are amino acids and D/L marks the configuration at each alpha-carbon.
Key structure-activity relationships
What the SAR then revealed is the part bench chemists will care about:
- D-configured residues: Favored in DKPs carrying aromatic amino acids (tryptophan, phenylalanine) or methionine.
- L-configured residues: Favored in DKPs carrying branched-chain amino acids.
- Proline substitutions: Swapping the proline for glycine nudged flux upward in some scaffolds.
In other words, the stereochemistry of a DKP is not cosmetic, it gates activity, and the rules track side-chain chemistry rather than ring geometry alone.
The mTORC1 question
The decisive control was Western blotting for phosphorylation of p70 S6K (Thr389) and 4EBP1, the two canonical readouts of mTORC1 kinase activity. Rapamycin wipes both signals. The four active DKPs did not.
Key point: The active DKPs raise autophagic flux through a mechanism that does not require detectable suppression of mTORC1 signaling.
The mechanistic target is still open—candidates include TFEB/TFE3 nuclear translocation, AMPK activation, calcium-dependent pathways, or direct engagement of the Beclin-1/VPS34 complex—but the dissociation from mTORC1 is established, not inferred.
What this means at the bench
If you are working with cyclic dipeptides, three practical points follow:
- Stereochemistry is a variable, not a footnote: Order your DKPs from a vendor that specifies configuration at every alpha-carbon and confirms it by chiral HPLC or NMR, and reject any lot shipped as a "racemic mixture" for SAR work.
- Store stocks dry and cold: Store lyophilized DKP stocks desiccated at -20 °C or colder. The cyclic backbone is stable, but residual water and trace acids will slowly epimerize free N-termini in linear precursors and degrade biological activity lot-to-lot.
- Always run mTORC1 controls: For cell-based autophagy assays, pair your GFP-LC3-RFP (or LC3-II / p62 Western) readout with a phospho-S6K or phospho-4EBP1 control so you can actually claim mTORC1-independent induction; without that control, you cannot distinguish a rapamycin-like hit from a novel mechanism.
The broader message is that the DKP scaffold is now a legitimate, stereochemically addressable starting point for autophagy drug discovery, and one that may finally let researchers decouple the benefits of autophagy induction from the metabolic costs of mTORC1 inhibition.
Frequently asked questions
What is a 2,5-diketopiperazine and why does stereochemistry matter?
A DKP is a six-membered cyclic dipeptide formed from two amino acids. Conventional synthesis racemizes the alpha-carbons, producing up to four stereoisomers per pair; a TycA-based chemoenzymatic route preserves configuration, which is essential for clean structure-activity analysis.
Which DKPs increased autophagic flux in the screen?
Four hits: c(DW-DP), c(DW-LP), c(DF-DP), and c(DM-LP), identified in Caco-2 cells expressing the tandem GFP-LC3-RFP autophagic flux probe.
Did these DKPs inhibit mTORC1?
No. The active DKPs did not detectably reduce phosphorylation of the mTORC1 downstream targets p70 S6K and 4EBP1, indicating their autophagy-inducing effect is mechanistically distinct from rapamycin-like mTORC1 suppression.
Prompted by this coverage at bioRxiv →
Sources
✔ Reviewed by Bryan Le, PharmD, RPh
Bryan is a licensed pharmacist (Doctor of Pharmacy, Registered Pharmacist). Reconstituting lyophilized preparations is core pharmacy practice, so he reviews The Lab’s content for technical accuracy and to keep it within a research-and-education scope, with no medical or dosing advice. View profile on LinkedIn.
Related from our lab: the pen · cartridges · bacteriostatic water · reconstitution calculators
Shared by PreppinPeppers for research, educational, and demonstration awareness only. We link to third-party coverage; we do not endorse it, and nothing here is medical advice or a recommendation to use any substance in humans or animals. Our products are sold for laboratory research use only.
Reminder: research and educational reference only. PreppinPeppers sells hardware and materials, not peptides. Not medical, dosing, or health advice, not evaluated by the FDA, and not intended for human or animal use.
